Post by Merz Therapeutics

Advancing our understanding of Parkinson’s Disease (PD) is a key part of how Merz Therapeutics strives to improve patient care. As a new EMJ publication highlights, gastrointestinal (GI) dysfunction may play an important role in symptom burden, oral medication uptake and treatment response in PD. The article explores how GI challenges such as delayed gastric emptying, constipation and dysphagia can affect the management of OFF-Episodes and why bypassing the GI tract may be a relevant treatment consideration for certain PD patients. Read the full article on EMJ via the link below. https://lnkd.in/d7smNUDm     #MerzTx #SpecialtyNeurology #EMJ